Clinical Trials
3 trialsNCT01308294 2020-06-11
LAG-3/IMP321
Centre Hospitalier Universitaire Vaudois
Phase 1/2 Terminated
NCT02676869 2019-12-18
TACTI-mel
Immutep Australia Pty. Ltd.
Phase 1 Completed
NCT00365937 2019-03-06
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 1/2 Terminated